AstraZeneca and GlaxoSmithKline have teamed up with the Carbon Trust to launch a tool to measure the carbon footprint of pills and tablets.
Pharmaceuticals account for about 20% of the NHS's carbon emissions. NHS England has pledged to cut its carbon footprint by 80% by 2050, but it is struggling in part due to an ageing population requiring more health care.
The new tool has been developed by the Carbon Trust, which says it is the first of its kind. It aims to help health care providers measure and manage their emissions from procuring pharmaceuticals. It will also help drug makers achieve their sustainability targets.